WeightWatchers CEO Explains Why ‘We Got It Wr...

Antidepressants are some of the most prescribed drugs in the US, but they may not be getting proper scrutiny. Dr. Sanjay Gupta talks to psychopharmacologist Dr. Joseph Goldberg about what to consider when stopping or starting one. Madeleine Thompson & Sofia Sanchez produced this ...  Show more

AI may be able to see things in your health records that a doctor wouldn’t... but it can also miss medical crises. AI researcher and urologist Dr. Ashwin Ramaswamy talks to Dr. Sanjay Gupta about using a chatbot for health guidance. Study mentioned in this episode: https://www.na ...  Show more

WeightWatchers recently announced a $132 million deal to acquire telehealth company Sequence and enter the prescription drug space (think: GLP-1 drugs like Wegovy and Ozempic). It begs the question: why is a company built on personal accountability facilitating medical interventi ...  Show more

WeightWatchers is struggling. Launched in the early 1960s, the brand grew by helping members shed pounds through behavioural change programmes. Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the ...

First there was Weight Watchers, then there was Noom, and now there’s…Wegovy? Bloomberg health reporter Emma Court helps us understand the evolution of dieting programs and where they’re going next. Later, Matthew Schnier of New York Magazine and The Cut walks us through his arti ...  Show more

Discover your why to totally shift the way you approach your wellness. Hosted by Leanne Vogel. Coaching and other supports available at: https://healthfulpursuit.com/coaching Podcast Sponsors, links and offers available at: http://ketodietpodcast.com/